Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

Fig. 3

Desmocollin 2 knock down and overexpression in TNBC cell lines. DSC2 knock down in MDA-MB-231-BR cells and DSC2 overexpression in MDA-MB-231 cells were performed and validated at mRNA level via qRT-PCR (A) and protein level using Western Blot (B). Additionally, membranous DSC2 expression was visualized and quantified by immunofluorescence (C) and flow cytometry (D)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us